Infinity Pharmaceuticals, Inc.
INFIDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001113148
Infinity Pharmaceuticals, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Infinity Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 93 | 2 | 78 | −13 |
| Shares | 39.0M | 127.7K | 30.0M | −8.82M (−22.7%) |
| Value | $44.3M | $146.0K | $19.0M | −$25.2M (−57.0%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Infinity Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 419,652 | $265.0K | 0.01% |
| Qube Research & Technologies Ltd | 81,968 | $52.0K | 0.00% |
| LMR Partners LLP | 41,631 | $26.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26.0K | 0.00% |
| Mackenzie Financial Corp | 27,182 | $17.0K | 0.00% |
| Merit Financial Group, LLC | 20,600 | $13.0K | 0.00% |
| Atria Wealth Solutions, Inc. | 20,000 | $13.0K | 0.00% |
| HRT Financial LP | 19,995 | $12.0K | 0.00% |
| Balyasny Asset Management LLC | 17,123 | $11.0K | 0.00% |
| Virtu Financial LLC | 16,636 | $11.0K | 0.00% |
| Man Group plc | – | $8.00K | 0.00% |
| UBS Group AG | 9,509 | $6.00K | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3.00K | 0.00% |
| Total Clarity Wealth Management, Inc. | 3,000 | $2.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 150 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 6 | $0 | 0.00% |
Sold out (29)
Institutions that held Infinity Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Infinity Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 113,808 | $130.0K |
| Amalgamated Financial Corp. | 13,875 | $16.0K |